Short-Term Debt to Equity Ratio: Xenon Pharmaceuticals (XENE)
Xenon Pharmaceuticals possesses immense pricing power due to the extremely low demand elasticity for severe epilepsy therapies. This daily price chart from GURU.Markets, where the indicator stands at 0.01, confirms market interest in selective ion channel inhibitors that reduce treatment toxicity. Upon approval of the breakthrough drug, patent protection will grant the company a monopoly and the right to set premium rates for insurers.
xenon-pharma.com (XENE) - metric breakdowns and financial figures
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Total Debt to Equity Ratio Xenon Pharmaceuticals|XENE - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Xenon|XENE - Company Cumulative Debt|Debt to Book Capitalization Ratio Xenon Pharmaceuticals Inc.|XENE - Company Long-Term Indebtedness|Company Short-Term Debt Xenon Pharmaceuticals|Quick Liquidity xenon-pharma.com
- company profitability and valuation multiples indicators:
Analysis of all company metrics:XENE Xenon Pharmaceuticals Inc
Financial stability is critical for Xenon Pharmaceuticals (XENE), as the seamless operation of temperature-controlled logistics chains requires confident liquidity management. By analyzing the ratio of short-term debt to equity, an investor assesses the company's ability to cover urgent loans with the market value of its assets, where the curve's dynamics determine the balance between default risk and the efficiency of financial leverage.
Who Xenon Pharmaceuticals competes with
Short-Term Debt to Capital BIIB|NBIX - Current Liabilities to Capital|Regencell Bioscience - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital axsome.com AXSM|ACAD - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Short-Term Debt to Equity|Current Liabilities to Capital Catalyst Corp (CPRX)|Short-Term Debt to Equity Ratio DNLI|Short-Term Debt to Capital Ratio HRMY (harmonybiosciences.com)|Short-Term Debt to Capital BHVN|AMLX - Current Liabilities to Capital|Short-Term Debt to Equity Trevi Pharma TRVI|PRAX: Short-Term Debt to Capital Ratio|AVXL - Short-Term Debt to Equity|Current Liabilities to Capital ceribell.com|Prothena Corp (PRTA) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio ALEC|Short-Term Debt to Equity Ratio ANNX|OMER: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Neurogene Inc. (NGNE)|ACIU: Current Liabilities to Equity|Short-Term Debt to Capital VYGR (Voyager Therapeutics, Inc.)|Ratio of Short-Term Indebtedness to Capital NMRA|Scilex Holding Co. - Short-Term Debt to Capital|TVGN - Short-Term Debt to Capital|alphacognition.com (ACOG) - Short-Term Debt to Equity|cogrx.com - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Inhibikase Therapeutics, Inc.|Short-Term Debt to Equity Ratio Cassava Sciences Inc (SAVA)|Short-Term Debt to Capital ASRT|Short-Term Debt to Capital coyatherapeutics.com (COYA)|Short-Term Debt to Capital VTGN (Vistagen)|OVID - Short-Term Debt to Equity Ratio|Acumen Pharmaceuticals, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital CervoMed, Inc.|ATHE (alteritytherapeutics.com) - Short-Term Debt to Equity Ratio|Clene (CLNN) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio PEPG|JUNS (jupiterneurosciences.com) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital RLMD|Short-Term Debt to Capital Coefficient Annovis Bio Inc|Short-Term Debt to Capital GRCE (Grace Therapeutics)|AIFF - Short-Term Debt to Equity Ratio|ANEW Medical, Inc. - Short-Term Debt to Capital|NRSN - Short-Term Debt to Capital|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Short-Term Debt to Equity|MTVA (MetaVia) - Short-Term Debt to Equity|Short-Term Debt to Equity NeurAxis, Inc|Helius Medical Technologies Inc. (HSDT) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio PASG (Passage Bio, Inc.)|bionomics.com.au - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital NERV (Minerva Neurosciences, Inc.)|Athira Pharma Inc (ATHA) - Current Liabilities to Capital|ADXN - Short-Term Debt to Equity|ALZN (Alzamend Neuro, Inc.) - Short-Term Debt to Capital Ratio|CYCN: Short-Term Debt to Capital|Current Liabilities to Capital Protagenic Therapeutics, Inc. (PTIX)|Short-Term Debt to Equity Pasithea Therapeutics Corp|Short-Term Debt to Capital Ratio CRGT (Cortigent Medical)|Short-Term Debt to Capital ATXI|BCLI - Current Liabilities to Capital|Cara Therapeutics, Inc. - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital chromocell.com CHRO|ELYM - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital ITCI (Intra-Cellular Therapies)|Longboard Pharma (LBPH) - Short-Term Debt to Equity|Current Liabilities to Capital Marinus Pharma (MRNS)|Short-Term Debt to Equity Ratio NKGN|Short-Term Debt to Capital Ratio NRBO (neurobopharma.com)|Short-Term Debt to Capital SAGE|SNPX - Current Liabilities to Capital|Short-Term Debt to Equity Trevena, Inc TRVN|VIGL: Short-Term Debt to Capital Ratio|WENA - Short-Term Debt to Equity|Current Liabilities to Capital cerevel.com